{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:00:03Z","timestamp":1791932403476,"version":"4.3.4"},"reference-count":33,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"MCS-JVAP","award":["W911QY-14-1-0001"],"award-info":[{"award-number":["W911QY-14-1-0001"]}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Previous studies demonstrated that a single intramuscular (i.m.) dose of an attenuated recombinant vesicular stomatitis virus (rVSV) vector (VesiculoVax vector platform; rVSV-N4CT1) expressing the glycoprotein (GP) from the Mayinga strain of\n                    <jats:named-content content-type=\"genus-species\">Zaire ebolavirus<\/jats:named-content>\n                    (EBOV) protected nonhuman primates (NHPs) from lethal challenge with EBOV strains Kikwit and Makona. Here, we studied the immunogenicities of an expanded range of attenuated rVSV vectors expressing filovirus GP in mice. Based on data from those studies, an optimal attenuated trivalent rVSV vector formulation was identified that included rVSV vectors expressing EBOV,\n                    <jats:named-content content-type=\"genus-species\">Sudan ebolavirus<\/jats:named-content>\n                    (SUDV), and the Angola strain of\n                    <jats:named-content content-type=\"genus-species\">Marburg marburgvirus<\/jats:named-content>\n                    (MARV) GPs. NHPs were vaccinated with a single dose of the trivalent formulation, followed by lethal challenge 28 days later with each of the three corresponding filoviruses. At day 14 postvaccination, a serum IgG response specific for all three GPs was detected in all the vaccinated macaques. A modest and balanced cell-mediated immune response specific for each GP was also detected in a majority of the vaccinated macaques. No matter the level of total GP-specific immune response detected postvaccination, all the vaccinated macaques were protected from disease and death following lethal challenge with each of the three filoviruses. These findings indicate that vaccination with a single dose of attenuated rVSV-N4CT1 vectors each expressing a single filovirus GP may provide protection against the filoviruses most commonly responsible for outbreaks of hemorrhagic fever in sub-Saharan Africa.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>IMPORTANCE<\/jats:bold>\n                    The West African Ebola virus Zaire outbreak in 2013 showed that the disease was not only a regional concern, but a worldwide problem, and highlighted the need for a safe and efficacious vaccine to be administered to the populace. However, other endemic pathogens, like Ebola virus Sudan and Marburg, also pose an important health risk to the public and therefore require development of a vaccine prior to the occurrence of an outbreak. The significance of our research was the development of a blended trivalent filovirus vaccine that elicited a balanced immune response when administered as a single dose and provided complete protection against a lethal challenge with all three filovirus pathogens.\n                  <\/jats:p>","DOI":"10.1128\/jvi.01190-17","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T11:15:27Z","timestamp":1510744527000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":44,"title":["Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge"],"prefix":"10.1128","volume":"92","author":[{"given":"Demetrius","family":"Matassov","sequence":"first","affiliation":[{"name":"Department of Virology and Vaccine Vectors, Profectus BioSciences Inc., Pearl River, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad E.","family":"Mire","sequence":"additional","affiliation":[{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, USA"},{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Latham","sequence":"additional","affiliation":[{"name":"Department of Virology and Vaccine Vectors, Profectus BioSciences Inc., Pearl River, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan B.","family":"Geisbert","sequence":"additional","affiliation":[{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, USA"},{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Immunology, Profectus BioSciences Inc., Pearl River, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayuko","family":"Ota-Setlik","sequence":"additional","affiliation":[{"name":"Department of Immunology, Profectus BioSciences Inc., Pearl River, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystle N.","family":"Agans","sequence":"additional","affiliation":[{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, USA"},{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean J.","family":"Kobs","sequence":"additional","affiliation":[{"name":"Battelle Memorial Institute, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan Q. S.","family":"Wendling","sequence":"additional","affiliation":[{"name":"Battelle Memorial Institute, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Burnaugh","sequence":"additional","affiliation":[{"name":"Battelle Memorial Institute, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Thomas L.","family":"Rudge","sequence":"additional","affiliation":[{"name":"Battelle Memorial Institute, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol L.","family":"Sabourin","sequence":"additional","affiliation":[{"name":"Battelle Memorial Institute, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Egan","sequence":"additional","affiliation":[{"name":"Department of Immunology, Profectus BioSciences Inc., Pearl River, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Clarke","sequence":"additional","affiliation":[{"name":"Department of Virology and Vaccine Vectors, Profectus BioSciences Inc., Pearl River, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Geisbert","sequence":"additional","affiliation":[{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, USA"},{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Eldridge","sequence":"additional","affiliation":[{"name":"Department of Virology and Vaccine Vectors, Profectus BioSciences Inc., Pearl River, New York, USA"},{"name":"Department of Immunology, Profectus BioSciences Inc., Pearl River, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"923","volume-title":"Fields virology","author":"Feldmann H","year":"2013","unstructured":"Feldmann H, Sanchez A, Geisbert T. 2013. Filoviridae: Marburg and Ebola viruses, p 923\u2013956. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed (electronic). Lippincott Williams & Wilkins, Philadelphia, PA.","edition":"6"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-010-0814-x"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001175"},{"key":"e_1_3_2_5_2","first-page":"101","article-title":"Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya","volume":"11","author":"Johnson ED","year":"1996","unstructured":"Johnson ED, Johnson BK, Silverstein D, Tukei P, Geisbert TW, Sanchez AN, Jahrling PB. 1996. Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch Virol Suppl 11:101\u2013114.","journal-title":"Arch Virol Suppl"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002304"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1405314"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61706-2"},{"key":"e_1_3_2_9_2","first-page":"618","article-title":"Isolation of the Isfahan virus in Turkmenia","volume":"1980","author":"Gaidamovich S","year":"1980","unstructured":"Gaidamovich S, Altukhova LM, Obukhova VR, Ponirovskii EN, Sadykov VG. 1980. Isolation of the Isfahan virus in Turkmenia. Vopr Virusol 1980:618\u2013620. (In Russian.)","journal-title":"Vopr Virusol"},{"key":"e_1_3_2_10_2","first-page":"1","article-title":"Estimating the future number of cases in the Ebola epidemic\u2014Liberia and Sierra Leone, 2014-2015","volume":"63","author":"Meltzer MI","year":"2014","unstructured":"Meltzer MI, Atkins CY, Santibanez S, Knust B, Petersen BW, Ervin ED, Nichol ST, Damon IK, Washington ML, Centers for Disease Control and Prevention. 2014. Estimating the future number of cases in the Ebola epidemic\u2014Liberia and Sierra Leone, 2014-2015. MMWR Suppl 63:1\u201314.","journal-title":"MMWR Suppl"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15012-X"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006608"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.09.076"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1586\/erv.10.152"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1258"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3702"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00561-09"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61117-5"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1502924"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00154-1"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01911-06"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.7.3501"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.5.3723-3732.1999"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01515-07"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03441-13"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv082"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv316"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature14428"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.4172\/2157-2526.S1-004","article-title":"Vesicular stomatitis virus-based vaccines for prophylaxis and treatment of filovirus infections","volume":"1","author":"Marzi A","year":"2011","unstructured":"Marzi A, Feldmann H, Geisbert TW, Falzarano D. 2011. Vesicular stomatitis virus-based vaccines for prophylaxis and treatment of filovirus infections. J Bioterror Biodef S1:2157\u20132526-S1-004.","journal-title":"J Bioterror Biodef"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890110110"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00045-7"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-9-159"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2006.02.006"},{"key":"e_1_3_2_34_2","volume-title":"Guide for the care and use of laboratory animals","year":"1996","unstructured":". 1996. Guide for the care and use of laboratory animals. New York Medical College\u2019s Institutional Animal Care and Use Committees, Tarrytown, NY."}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.01190-17","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.01190-17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T09:38:37Z","timestamp":1646473117000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.01190-17"}},"subtitle":[],"editor":[{"given":"Terence S.","family":"Dermody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1128\/JVI.01190-17"],"URL":"https:\/\/doi.org\/10.1128\/jvi.01190-17","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732122440.793555418","asserted-by":"object"}]},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"2017-07-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-10-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01190-17"}}